Publication date: Jan 03, 2025
“Patients with kidney disease are at high risk for adverse outcomes after COVID-19 despite vaccination,” the study authors noted. “Rates of death have improved with the introduction of COVID-19 vaccines, but they remain high in patients with advanced kidney disease. “Fewer heart issues earlier in kidney diseaseIn total, 94% of patients had pre-dialysis CKD, and 6% had kidney failure.
| Concepts | Keywords |
|---|---|
| Diabetes | Adverse |
| Hospitalization | Ckd |
| July | Covid |
| Massachusetts | Death |
| Women | Disease |
| Events | |
| Failure | |
| High | |
| Kidney | |
| Long | |
| Lower | |
| Patients | |
| Paxlovid | |
| Risk | |
| Vaccination |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | role |
| disease | MESH | myocardial infarction |
| disease | MESH | ‘long COVID |
| disease | MESH | coronary artery disease |
| disease | MESH | death |
| disease | MESH | kidney disease |
| drug | DRUGBANK | Ritonavir |
| disease | MESH | COVID-19 |
| disease | MESH | chronic kidney disease |
| pathway | REACTOME | Disease |
| disease | IDO | disease |
| disease | MESH | kidney failure |
| disease | MESH | Infectious Diseases |
| disease | MESH | high blood pressure |
Original Article
(Visited 1 times, 1 visits today)